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Summary
FOXO3A variation has repeatedly been reported to associate with
human longevity, yet only few studies have investigated
whether FOXO3A variation also associates with aging-related
traits. Here, we investigate the association of 15 FOXO3A tagging
single nucleotide polymorphisms (SNPs) in 1088 oldest-old Danes
(age 92–93) with 4 phenotypes known to predict their survival:
cognitive function, hand grip strength, activity of daily living
(ADL), and self-rated health. Based on previous studies in humans
and foxo animal models, we also explore self-reported diabetes,
cancer, cardiovascular disease, osteoporosis, and bone (femur/
spine/hip/wrist) fracture. Gene-based testing revealed significant
associations of FOXO3A variation with ADL (P = 0.044) and bone
fracture (P = 0.006). The single-SNP statistics behind the gene-
based analysis indicated increased ADL (decreased disability) and
reduced bone fracture risk for carriers of the minor alleles of 8
and 10 SNPs, respectively. These positive directions of effects are
in agreement with the positive effects on longevity previously
reported for these SNPs. However, when correcting for the test of
9 phenotypes by Bonferroni correction, bone fracture showed
borderline significance (P = 0.054), while ADL did not (P = 0.396).
Although the single-SNP associations did not formally replicate
in another study population of oldest-old Danes (n = 1279, age
94–100), the estimates were of similar direction of effect as
observed in the Discovery sample. A pooled analysis of both
study populations displayed similar or decreased sized
P-values for most associations, hereby supporting the initial
findings. Nevertheless, confirmation in additional study popula-
tions is needed.
Key words: aging phenotypes; association study; Forkhead
box O3; oldest-old; SNPs.
Introduction
Genetic factors contribute to the variation in human lifespan as well as to
aging-related traits such as physical and cognitive function (Frederiksen
et al., 2002; McGue & Christensen, 2002; Hjelmborg et al., 2006). The
forkhead box O3 gene (FOXO3A) may, due to the verification in several
study populations (Willcox et al., 2008; Anselmi et al., 2009; Flachsbart
et al., 2009; Li et al., 2009; Pawlikowska et al., 2009; Soerensen et al.,
2010; Zeng et al., 2010; Di Bona et al., 2013; Bao et al., 2014; Broer
et al., 2014), be considered a second consistently confirmed longevity-
associated gene in addition to the apolipoprotein E gene (APOE).
However, only few studies have investigated whether FOXO3A variation
might also associate with aging-related phenotypes in the oldest-old.
FOXO3A is part of the insulin/insulin-like growth factor 1 signaling
pathway, one of the key candidate pathways of longevity (Christensen
et al., 2006). Together with FOXO1A, FOXO4, and FOXO6, FOXO3A
constitutes the FoxO family of transcription factors, which regulates the
expression of numerous downstream genes involved in a wide range of
biological processes including apoptosis, cell cycle transition, DNA repair,
oxidative stress, cell differentiation, and glucose metabolism (reviewed in
(Huang & Tindall, 2007)).
Several animal studies have aimed to shed light on the physiological
effects of loss-of-function or overexpression of foxo3a or its homo-
logues. For example, lack of foxo in fruit flies (Drosophila Melanogaster)
was, among other things, observed to increase the sensitivity to oxidative
stress (Junger et al., 2003), while overexpression in the fat body was
reported to reduce fecundity and increase lifespan in females (Gian-
nakou et al., 2004). In zebra fish (Danio rerio), neural developmental
defects were detected after knockdown of foxo3a, an effect likely
mediated via increased apoptosis (Peng et al., 2010). In mice (Mus
musculus) knockout of Foxo3 has for instance been found to cause
hematological abnormalities, decreased glucose uptake in glucose
tolerance tests, and increased follicular activation, the latter leading to
depletion of functional follicles, oocyte death, and infertility in female
mice (Castrillon et al., 2003). In other mouse studies, Foxo3 knockout
induced incorrect immune responses, among others manifested as
reduced numbers of B-cells (Hinman et al., 2009) and auto inflammation
(Lin et al., 2004). Furthermore, Foxo3 knockout has been reported to
affect the maintenance of hematopoietic stem cells; for example,
manifested as reduced autophagy after metabolic stress (Warr et al.,
2013) and as reduced self-renewal in general, the latter likely impairing
the maintenance of the stem cells during aging (Miyamoto et al., 2007).
Tissue-specific mouse models have also been made, for instance cardiac-
specific constitutive expression of foxo3was, among others, described to
result in decreased heart weight (Schips et al., 2011), while constitutive
expression in rat substantia nigra led to neuronal loss (Pino et al., 2014).
Finally, as foxo1, foxo3, and foxo4 have overlapping functions, condi-
tional triple knockout mice have been generated (reviewed in (Arden,
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2008)). These mice were, among other things, reported to have
decreased insulin levels in liver-specific knockouts (Haeusler et al.,
2010), increased numbers of thymic lymphomas and hemangiomas
(Paik et al., 2007), and reduced bone formation and bone mass
(Ambrogini et al., 2010). In the latter study, osteoblast-specific overex-
pression of foxo3 was found to increase bone formation (Ambrogini
et al., 2010).
A few studies in humans have explored the association between
FOXO3A variation and aging-related phenotypes in the oldest-old.
Kuningas et al. (2007) observed an increased risk of stroke, but not of
diabetes or cardiovascular disease (CVD), in elderly carriers of two
specific FOXO3A haplotypes. A borderline significant association was
seen for cardiovascular mortality risk, yet not for cancer mortality risk.
Willcox et al. (2008) found no significant association of rs2802292 with
stroke, diabetes, coronary heart disease, or cancer when long-lived
individuals were investigated separately. However, when average-lived
individuals from the same birth cohorts were included, the single
nucleotide polymorphism (SNP) displayed association with coronary
heart disease and health status. Also, a borderline significant association
with cancer was noted. Pawlikowska et al. (2009) examined rs1935949
and rs4946935 in long-lived individuals and participants of their
prospective cohort, who died from specific causes. rs4946935 showed
association with death caused by cancer, while both SNPs showed
association with death caused by atherosclerosis. Although a replication
sample did not reveal significance, meta-analyses did support the
associations.
To further explore whether FOXO3A variation associates with aging-
related traits likely influencing longevity, we investigated the association
of 15 FOXO3A tagging SNPs with phenotypes previously shown to
predict survival in the oldest-old studied here (Nybo et al., 2003):
cognitive function, physical function (as measured by hand grip
strength), activity of daily living (ADL), and self-rated health. In addition,
we also explored the prevalence of self-reported diabetes, cancer, CVD,
osteoporosis, and bone (femur/spine/hip/wrist) fracture (bone fracture).
Results
The characteristics of the study populations are shown in Table S1
(Supporting information), while the 15 FOXO3A SNPs are given in Fig. 1.
Gene-based association study in the Discovery sample
To investigate the overall association of FOXO3A variation with the nine
phenotypes, a gene-based analysis was performed. The data are
summarized in Table 1. Only ADL and self-reported bone fracture
displayed p-gene values below 0.05: p-gene (ADL) = 0.044 and p-gene
(bone fracture) = 0.006. These p-gene values are corrected for the test of
15 SNPs, but not for the test of nine phenotypes. When conducting a
strict Bonferroni correction, the association of FOXO3A variation with
bone fracture was borderline significant (p-gene = 0.054), while the
association of FOXO3A variation with ADL was not (p-gene = 0.396).
Effects at the single-SNP level for ADL and bone fracture
The gene-based analysis gives no overall effect estimate. Hence, the
direction of effect of the associations observed at the gene-level must be
represented by the size and direction of effect of the coefficients of the
single-SNP tests, which were the basis of the gene-based analysis. These
data are summarized in Table 2. Five of the 15 SNPs showed p-SNP
values below 0.05 for ADL, while 3 SNPs showed nonsignificant
borderline association (p-SNPs: 0.055–0.074). For the minor alleles of
all of these SNPs the direction of effect on ADL was positive,
corresponding to a decreased disability (see Table 2A). With respect to
bone fracture, 10 of the 15 SNPs showed P-values below 0.05. Again,
Fig. 1 Linkage disequilibrium plot of the
15 FOXO3A SNPs under study. Notes: The
values are R2 (a value of 100 reflects
complete dependency between SNPs), and
the colors reflect R2 (the darker color the
higher the R2). kb: kilobases.
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the direction of effect was positive for all minor alleles of these SNPs,
corresponding to a decreased risk of bone fracture (see Table 2B).
Replication study of the ADL and bone fracture findings
Five SNPs were investigated in the Replication sample: rs12206094,
rs2802292, rs3800231, rs479744, and rs7762395 (see Experimental
procedures). None of the initial findings could be formally replicated.
However, all of the effect estimates observed in the Replication sample
were in the same direction, although generally attenuated, as compared
to the Discovery sample (compare Table 3A to B, and Table 3D to E).
In a pooled analysis of the data from both study populations, all five
SNPs showed nominal or borderline significant (p-SNP>0.05 < 0.10)
association with bone fracture, and the significance was increased for
rs2802292 and rs479744 as compared to the Discovery sample (compare
Table 3D to F). With respect to ADL, rs12206094, rs2802292, and
rs3800231 showed nominal or borderline significant association in the
pooled analysis and furthermore showed lower sized p-SNP values as
compared to the Discovery sample (compare Table 3A to C). The effect
estimates of the pooled analysis were of the same direction, as
compared to the analyses in the Discovery sample alone and in the
Replication sample alone.
Discussion
In this study, we investigated the association of variation in the second
consistently confirmed longevity-associated gene, FOXO3A, with aging-
related phenotypes in the oldest-old. In the Discovery sample, we
explored four phenotypes known to predict their survival, that is,
cognitive function, self-reported health, hand grip strength, and ADL.
Moreover, we included data on five self-reported diseases: diabetes,
cancer, CVD, osteoporosis, and bone fracture, as these are either
investigated in genetic association studies and/or are supported by foxo
animal models.
We found FOXO3A variation to show nominal significant association
with two of the investigated phenotypes; ADL and bone fracture (see
Table 1). This does, however, not exclude relevance of FOXO3A variation
for the remaining seven phenotypes or for the physiological processes
behind these phenotypes; it is possible that more statistical power is
needed to detect such associations, especially if these are of small effect
size (see Experimental procedures). Furthermore, as the foxo3a protein
has a wide array of downstream targets, which themselves affect a wide
range of cellular and physiological processes, it may simply be difficult to
pinpoint the candidate phenotypes, which FOXO3A potentially affects.
Contrary to our results, two previous studies (Willcox et al., 2008;
Pawlikowska et al., 2009) described association of single FOXO3A SNPs
with cancer and health status, respectively. In a retrospective lookup,
none of these associations could, however, be replicated in our data
(data not shown). The lack of concordance could be due to differences in
phenotypes or study designs, for example the present study investigates
oldest-old only, while early dying controls were included in the other
studies. Hence, it might be speculated that FOXO3A influences health
status and cancer prevalence only at younger ages. That associations can
change with age has been described previously (Jacobsen et al., 2010).
Similarly, due to the study by Kuningas et al. (2007), we performed a
retrospective analysis of CVD data restricting to stroke and found no
Table 1 Gene-based association of FOXO3A variation and the nine phenotypes in
the Discovery sample
Phenotype n p-gene
Cognitive composite score 1026 0.851
Self-reported CVD 1086 0.777
Hand grip strength 980 0.281
Self-reported diabetes 1087 0.228
Self-reported cancer 1085 0.226
Self-reported osteoporosis 1061 0.221
Self-rated health 1040 0.163
Activity of daily living 1086 0.044
Self-reported bone fracture 1063 0.006
n, number of individuals with data (in total 1088 individuals were genotyped);
p-gene, set-based value obtained after 10000 permutations; CVD, cardiovascular
disease. p-gene values < 0.05 are shown in bold.
Table 2 Single-SNP analysis in the Discovery sample of FOXO3A variation and (A) activity of daily living and (B) bone (femur/spine/hip/wrist) fracture
(A) Activity of daily living (n = 1086) (B) Bone fracture (n = 1063)
SNP b-coef. p-SNP 95% CI SNP OR p-SNP 95% CI
rs9400239 0.07 0.020 0.01; 0.14 rs9486902 0.60 0.001 0.45; 0.81
rs9398172 0.07 0.021 0.01; 0.14 rs7762395 0.57 0.001 0.42; 0.78
rs13217795 0.07 0.024 0.01; 0.14 rs479744 0.69 0.007 0.52; 0.90
rs2802292 0.07 0.026 0.01; 0.13 rs3800231 0.72 0.008 0.57; 0.92
rs2764264 0.07 0.042 0.01; 0.13 rs9398172 0.74 0.012 0.58; 0.94
rs479744 0.07 0.055 0.01; 0.14 rs9400239 0.75 0.017 0.59; 0.95
rs3800231 0.06 0.063 0.01; 0.12 rs2764264 0.75 0.020 0.59; 0.96
rs7762395 0.07 0.074 0.01; 0.15 rs13217795 0.76 0.028 0.60; 0.97
rs10499051 0.08 0.133 0.02; 0.18 rs12206094 0.77 0.035 0.61; 0.98
rs12206094 0.05 0.149 0.02; 0.11 rs2802292 0.80 0.049 0.64; 0.99
rs9486902 0.05 0.171 0.02; 0.13 rs13220810 0.88 0.303 0.70; 1.12
rs3800232 0.04 0.392 0.05; 0.13 rs12207868 1.17 0.362 0.83; 1.65
rs12207868 0.01 0.828 0.09; 0.11 rs10499051 1.12 0.549 0.78; 1.61
rs12212067 0.01 0.869 0.09; 0.10 rs3800232 0.94 0.711 0.68; 1.30
rs13220810 -0.01 0.905 0.07; 0.06 rs12212067 1.03 0.874 0.73; 1.45
The single-SNP tests were the basis of the gene-set analysis in the Discovery sample. n, number of individuals with data; b-coef., beta coefficient; OR, odds ratio; CI,
confidence interval; p-SNP values < 0.05 are shown in bold, while p-SNP values > 0.05 < 0.10 are shown in bold and italics.
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association (data not shown). This is, however, in accordance with the
previous study, as they only found haplotype specific and not single
variant specific associations (Kuningas et al., 2007). A few additional
studies have indicated association of FOXO3A variation with insulin
sensitivity, for example fasting insulin levels, in young and/or elderly
individuals (Willcox et al., 2008; and Banasik et al., 2011). As we did not
have data on insulin sensitivity, we could not test this. However, we did
not find any association with self-reported diabetes. One explanation
could be that such an association is most relevant at younger ages and
not among the oldest-old.
The single-SNP statistics behind the gene-based analyses of ADL and
bone fracture indicated positive effects of the minor alleles of the
majority of the 15 FOXO3A SNPs; that is, increased ADL (decreased
disability) and reduced risk of bone fracture. The associations were,
however, not statistically significant for all SNPs (see Tables 2A,B).
Further supporting an effect of variation in FOXO3A on ADL and bone
fracture, it can be noticed that the 15 SNPs were distributed over the
entire gene region and that, at least for some of the SNPs, there was
rather modest linkage disequilibrium (LD) (see Fig. 1). Hence, it seems
that the estimates, obtained for either ADL or bone fracture, are not
completely redundant. Furthermore, it might also suggest that the
findings are not chance findings.
Our findings are strengthened by the fact that for all of the 8 SNPs
suggested to associate with ADL and the 10 SNPs associated with bone
fracture, the minor alleles (or the minor alleles of their proxies (R2 > 0.8))
have previously been reported to pose a positive effect on human
longevity in between 1 and 5 studies (Willcox et al., 2008; Anselmi
et al., 2009; Flachsbart et al., 2009; Li et al., 2009; Pawlikowska et al.,
2009; Soerensen et al., 2010; Zeng et al., 2010; Broer et al., 2014). This
convincing overlap in SNP associations could indicate an influence of
FOXO3A variation directly on both the aging phenotypes and on
longevity or it might alternatively suggest that an effect on the aging
phenotypes could affect longevity.
Interestingly, 8 of the 15 FOXO3A SNPs showed borderline or nominal
significant association with both ADL and bone fracture, and the
coefficients for both phenotypes showed the same direction of effect. In
retrospective regression analyses of ADL and each of these SNPs
additionally adjusting for bone fracture, significance was observed
between ADL and bone fracture, and the associations between ADL and
the SNPs were slightly attenuated (data not shown). The SNP associa-
tions were, however, still found to be significant or borderline significant
(data not shown). The same was found when additionally adjusting the
regression analyses of bone fracture and each SNP for ADL (data not
shown). The associations observed between ADL and bone fracture
imply that the associations between the FOXO3A SNPs and the two
phenotypes could partly be due to shared underlying factors, while the
preservation of (borderline) significance for the SNPs implies that the
associations with the two phenotypes must also be explained by
nonshared underlying factors. Considering that FOXO3A affects a wide
range of target genes, which in turn influence various biological
processes, the potential shared and nonshared factors are numerous.
The association between FOXO3A variation and bone fracture was
not accompanied by a concurrent association with osteoporosis.
However, these two phenotypes cannot be expected to be completely
interchangeable, as osteoporosis is often underdiagnosed and under-
treated in Denmark (Eiken & Abrahamsen, 2010). This aspect appears to
be reflected in the prevalence of bone fracture and osteoporosis in the
Discovery sample; despite some concordance between the two pheno-
types (P-value (v2 test) < 0.001), only 9.2% of the individuals reported
an osteoporosis diagnosis, while 25% reported a bone fracture.
Furthermore, due to the nature of the survey data, we cannot affirm
that all fractures are osteoporotic; for this end, information on high- or
low-energy fractures and the age at the time of fracture would be
needed, that is, low-energy fractures occurring at higher ages would be
more likely to be osteoporotic. Nevertheless, when retrospectively
inspecting the coefficients of the single-SNP analysis of osteoporosis, 9
Table 3 Replication study of activity of daily living and bone fracture findings
Activity of daily living
SNP
(A) ADL in Discovery sample (n = 1086) (B) ADL in Replication sample (n = 1279) (C) ADL Pooled analysis
b-coef. p-SNP 95% CI b-coef. p-SNP 95% CI b-coef. p-SNP 95% CI
rs2802292 0.07 0.026 0.01; 0.13 0.04 0.183 0.02; 0.09 0.05 0.017* 0.01; 0.09
rs479744 0.07 0.055 0.01; 0.14 0.02 0.582 0.05; 0.09 0.04 0.112 0.01; 0.09
rs3800231 0.06 0.063 0.01; 0.12 0.03 0.331 0.03; 0.09 0.04 0.054* 0.01; 0.09
rs7762395 0.07 0.074 0.01; 0.15 0.03 0.514 0.05; 0.10 0.04 0.114 0.01: 0.10
rs12206094 0.05 0.149 0.02; 0.11 0.04 0.202 0.02; 0.10 0.04 0.069* 0.01; 0.08
Bone fracture
SNP
(D) BF in Discovery sample (n = 1063) (E) BF in replication sample (n = 691) (F) BF Pooled analysis
OR p-SNP 95% CI OR p-SNP 95% CI OR p-SNP 95% CI
rs7762395 0.57 0.001 0.42; 0.78 0.90 0.542 0.64; 1.26 0.71 0.003 0.56; 0.89
rs479744 0.69 0.007 0.52; 0.90 0.86 0.311 0.63; 1.16 0.76 0.006* 0.62; 0.92
rs3800231 0.72 0.008 0.57; 0.92 0.88 0.361 0.68; 1.15 0.80 0.012 0.67; 0.95
rs12206094 0.77 0.035 0.61; 0.98 0.97 0.817 0.73; 1.28 0.85 0.085 0.71; 1.02
rs2802292 0.80 0.049 0.64; 0.99 0.87 0.287 0.67; 1.12 0.83 0.033* 0.70; 0.99
ADL, activity of daily living; n, number of individuals with data; b-coef., beta coefficient; CI, confidence interval; BF, bone fracture; OR, odds ratio; *SNPs for which the
pooled analysis showed lower p-SNPs as compared to the analysis of the Discovery sample alone.
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of the 10 SNPs, which showed a nominal significant positive effect on
bone fracture, also indicated a positive effect on osteoporosis, although
it was not statistically significant (data not shown).
We could not formally replicate the associations of FOXO3A variation
with ADL and bone fracture in another sample of Danish oldest-olds.
There are a number of possible reasons for this. First of all, it may indicate
that these were merely chance findings or that the Replication sample
could be underpowered with respect to small effect sizes. However,
another explanation could be that the individuals of the Replication
sample were slightly older (94.7–100.9 years) than the individuals of the
Discovery sample (92.2–93.8 years). This could potentially be of impor-
tance if the associations are not constant with age. As mentioned earlier,
such changes in association with age have been reported previously
(Jacobsen et al., 2010). Still, the Replication sample was the best
obtainable study population, as the Replication sample was surveyed
using the exact same questionnaire and assessment instrument as the
Discovery sample. Finally, the effect estimates are of critical importance
(Olsen et al., 2010) and for the majority of the SNPs, the effect estimates
[b-coefficients and odds ratios (ORs)] of the Replication sample had similar
direction as those observed in the Discovery sample (Table 3). In the
pooled analysis (Table 3), this was further supported by comparable
direction of the effect estimates and by a lowering of p-SNP values for
some of the SNPs. In general, we believe that these findings lend
suggestive support to the associations seen in the Discovery sample,
although additional studies are needed to enable conclusion.
In this study, we for the first time suggest the association of variation in
the second consistently confirmed longevity-associated gene, FOXO3A,
with ADL and bone fracture. Such effects could mediate the influence of
FOXO3A variation on longevity; however, further explorations in addi-
tional study populations are needed before conclusions can be drawn.
Experimental procedures
Subjects
The Discovery sample was 1200 participants randomly drawn from 1651
eligible members of the Danish 1905 Birth Cohort Study (Nybo et al.,
2001), a nationwide survey of an entire birth cohort. The FOXO3A
genotype data set is described in (Soerensen et al., 2010, 2012). After
data cleaning, data were available for 1088 individuals with an age
range of 92.2–93.8 years (mean: 93.1 years) and a gender distribution
of 29% males and 71% females.
For replication of the findings observed in the Discovery sample, we
used data on 1279 individuals from two additional population-based
surveys of oldest-old Danes: the Danish 1910 and 1915 Birth Cohort
Studies (unpublished data and (Christensen et al., 2013)). These surveys
were conducted similar to the Danish 1905 Birth Cohort Study. The age
range was 94.7–100.9 years (mean: 96.0 years), and the gender
distribution was 27% males and 73% females.
Permission to collect blood samples and to use survey information was
granted by The Danish Regional Committees on Biomedical Research
Ethics.
Genotype data
The 15 FOXO3A SNPs investigated in the Discovery sample are located in
position 108982719–109113664 of chromosome 6, which corresponds
to FOXO3A and 5000 base pairs (bp) upstream and 1000 bp
downstream (NCBI assemble 36). Details on how these FOXO3A SNPs
were chosen and the generation of Illumina GoldenGate (Illumina Inc.,
San Diego, CA, USA) genotype data were previously described
(Soerensen et al., 2010, 2012). The LD plot in Fig. 1 is based on the
genotype data of the Discovery sample, and the plot was generated
in the Haploview software (http://www.broadinstitute.org/scientific-
community/science/programs/medical-and-population-genetics/haploview/
haploview, (Barrett et al., 2005)).
Toperforma replication study of the initial findings, the LDpatternof the
10 SNPs, which showed significance in the Discovery sample, was
investigated in the SNAP Proxy database (http://www.broadinstitute.org/
mpg/snap/ldsearch.php). The r2 > 0.8 criterion was used with data from
the1000Genomesproject (Abecasiset al., 2010).Consequently, fiveSNPs,
rs12206094, rs2802292, rs3800231, rs479744 and rs7762395, were
selected, which in general cover the same genetic variation as the 10 SNPs
found to be significant in the Discovery sample. The DNA of the Replication
sample was purified from blood spot cards using the Extract-N-AmpTM
Blood PCR Kit (Sigma Aldrich, St. Louis, MO, USA), and genotyping was
performed by standard TaqMan procedures, using predesigned TaqMan
SNP Genotyping Assays (Applied Biosystems, Foster City, CA, USA).
Phenotype data
The phenotype data for all surveys were collected as part of a
comprehensive home-based interview focusing on health and disease
issues. Cognitive function was assessed by a cognitive composite score,
which investigates verbal fluency, forward and backward digit span, and
immediate and delayed recall (McGue & Christensen, 2002). Handgrip
strength was determined using a handheld dynamometer (SMEDLEY’S
dynamometer, Scandidact, Kvistgaard, Denmark); the maximum of three
measurements with the strongest hand was used. Self-rated health was
assessed by the question ‘How do you consider your health in general?’
with five response categories: very poor, poor, acceptable, good, and
excellent. ADL was inspected by a five-item ADL disability score (based on
the Katz ADL index (Katz et al., 1970)) about bathing, dressing, toileting,
transfer and feeding; the score was categorized into ‘disabled = could do
maximum two items’, ‘moderately disabled = could do three or four items,
‘ or ‘not disabled = could do all five items. ‘ Self-reported status on cancer,
osteoporosis, and diabetes was evaluated by asking: ‘Did a doctor ever tell
you that you have/had any of the following diseases? ‘ with the response
categories ‘has nowor has had‘ and ‘no. ‘ Self-reportedCVDwas obtained
in the same way, yet with six diseases combined in one group; stroke,
heart attack, angina pectoris, irregular heart rhythm, other heart
problems, and treatment for hypertension with prescription medicine/
drop. Self-reported fracture of the femur, spine, hip, and/or wrist was
investigated, as these types of fractures are considered typical osteopo-
rotic frailty fractures and likely indicate low bone density (Nguyen et al.,
2001; Bathum et al., 2004; Broderick et al., 2013). Status on bone
fracture was evaluated by asking ‘Did you fracture a bone after the age of
40? ‘, and if the answer was ‘yes‘ subsequently asking: ‘Where did you
have the fracture? ‘ with five response categories ‘femur, ‘spine (also
collapse), ‘hip, ‘wrist, ‘ and ‘other places. ‘ The individuals, whom reported
at least 1 fracture of the femur, spine, hip, and/or wrist after age 40, were
compared to the rest of the study population.
The phenotype data used for the Replication sample were based on
data from the respective surveys, and the questions were identical to the
questions in the Danish 1905 Birth Cohort Study.
Statistical analyses
Set(gene)-based analyses of the 15 FOXO3A SNPs and each of the nine
phenotypes were performed in Plink (Purcell et al., 2007); applying the
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most inclusive settings, that is set-max 99999, set-r2 1, and set-p 1. In the
set-based test, linear regression was applied for analysis of the cognitive
composite score, hand grip strength, ADL, and self-rated health, while
logistic regressionwas used for analysis of status on cancer, diabetes, CVD,
osteoporosis, and bone fracture. All set-based analyses were adjusted for
age and sex, while the set-based analysis of the cognitive composite score
was additionally adjusted for level of education (<7th grade, 7th–8th
grade, 9th–10th grade or >11th grade), the set-based analysis of
self-reported cancerwas additionally adjusted for smoking status (current,
former, or never smoker), the set-based analyses of handgrip strength and
self-reported diabetes were additionally adjusted for body mass index
(bmi), the set-based analysis of self-reported CVD was additionally
adjusted for bmi and smoking status, and the set-based analyses of
self-reported bone fracture and osteoporosis were additionally adjusted
for bmi, smoking status, and hormone use after menopause (hormone
therapy or no hormone therapy). In the set-based analysis, the single-SNP
P-values are summarized by their overall mean, while considering LD;
hence, the analysis estimates the average association of the FOXO3A SNPs
with a given phenotype. The significance (p-gene) was determined by
repeating this for 10000 permutations of the phenotype, consequently
correcting for the test of 15 SNPs.
Analysis of the genotype and phenotype data from the Replication
sample was performed by single-SNP analysis using the same single-SNP
statistics as described above as part of the set-based test conducted for
the Discovery sample. The analysis of bone fracture was restricted to the
691 individuals of the Replication sample for whom data on bmi were
available. All replication analyses were done in the STATA 11.0 software
(Stata Corporation, College Station, TX, USA).
Power calculations
The set(gene)-based method applied in the present study is a power-full
approach as it tests a group of SNPs in a gene and hereby increases
power as compared to testing the individual SNPs separately. However,
power calculations for set(gene)-based approaches are unfortunately not
yet available. To inspect the effect sizes obtainable with good certainty
(power>0.8) in the single-SNP analysis in the Discovery sample, we
performed power calculations in the Quanto software (version Quan-
to1_2_4a, http://biostats.usc.edu/cgi-bin/DownloadQuanto.pl) assuming
an additive model. For SNPs with a minor allele frequency (MAF) of 0.4,
ORs of moderate size (OR < 0.60–0.78) should be obtainable for the
binary phenotypes, while for a MAF of 0.1 sizeable ORs (ORs < 0.36–
0.66) should be attainable. For the cognitive composite score, hand grip
strength, ADL, and self-rated health, rather small beta-coefficients
should be obtainable for a MAF of 0.4: >0.43, >0.86, >0.09 and >0.12,
respectively (0.13 of a standard deviation for all four phenotypes). The
same was true for the less frequent variants (MAF 0.1), where the values
were >0.70, >1.42, >0.14, and >0.19, respectively (0.21of a standard
deviation for all four phenotypes).
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